GlassScriptPhysician profile
Karen A Paczkowski
NPI 1326000290
$1,019.78
in general payments reported to CMS, 2019-2025
17 companies · $567 in 2025
The $567 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $203 · 2022: $33.38 · 2023: $195 · 2024: $22.10 · 2025: $567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $783.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $233.77 | 2021-2025 | |
| Novo Nordisk INC | $178.79 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $90.42 | 2021-2025 | Jardiance, Zepbound, Mounjaro |
| Glaxosmithkline, LLC. | $80.16 | 2021-2023 | Arexvy |
| Eisai INC. | $68.08 | 2025 | |
| Abbott Laboratories | $59.88 | 2023 | Freestyle Libre 2 |
| E.R. Squibb & Sons, L.L.C. | $59.48 | 2023-2025 | Eliquis, Camzyos |
| Amgen INC. | $53.63 | 2022-2025 | Otezla, Repatha |
| Amarin Pharma, INC. | $31.28 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.74 | 2021-2022 | |
| Scpharmaceuticals INC. | $29.54 | 2025 | |
| Tandem Diabetes Care, INC. | $24.40 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Novartis Pharmaceuticals Corporation | $22.10 | 2024 | |
| Merck Sharp & Dohme LLC | $17.41 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.97 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $13.86 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $13.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Paczkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.